Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression

[1]  K. Seyb,et al.  Identification of Translational Activators of Glial Glutamate Transporter EAAT2 through Cell-Based High-Throughput Screening , 2010, Journal of biomolecular screening.

[2]  Noo Li Jeon,et al.  Presynaptic Regulation of Astroglial Excitatory Neurotransmitter Transporter GLT1 , 2009, Neuron.

[3]  J. Rothstein,et al.  Current hypotheses for the underlying biology of amyotrophic lateral sclerosis , 2009, Annals of neurology.

[4]  James Inglese,et al.  A specific mechanism for nonspecific activation in reporter-gene assays. , 2008, ACS chemical biology.

[5]  J. Rothstein,et al.  Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS , 2007, Brain Research.

[6]  W. Colledge.  Faculty Opinions recommendation of Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. , 2005 .

[7]  P. Fisher,et al.  β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression , 2005, Nature.

[8]  Jian Wang,et al.  Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine. , 2004, Biochemical and biophysical research communications.

[9]  F. Aricioglu,et al.  Effect of Harmane on the Convulsive Threshold in Epilepsy Models in Mice , 2003, Annals of the New York Academy of Sciences.

[10]  G. Bishop,et al.  Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice. , 2003, Human molecular genetics.

[11]  D. Howland,et al.  Impaired Spinal Cord Glutamate Transport Capacity and Reduced Sensitivity to Riluzole in a Transgenic Superoxide Dismutase Mutant Rat Model of Amyotrophic Lateral Sclerosis , 2003, The Journal of Neuroscience.

[12]  J. Rothstein,et al.  Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  V. Meininger,et al.  Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients , 2002, Journal of the Neurological Sciences.

[14]  E. Louis,et al.  TOXICOKINETICS OF TREMOROGENIC NATURAL PRODUCTS, HARMANE AND HARMINE, IN MALE SPRAGUE-DAWLEY RATS , 2001, Journal of toxicology and environmental health. Part A.

[15]  D. Nutt,et al.  β-carboline binding to imidazoline receptors , 2001 .

[16]  N. Danbolt.  Glutamate uptake , 2001, Progress in Neurobiology.

[17]  R. Glennon,et al.  Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors , 2000 .

[18]  T. Sourkes,et al.  "Rational hope" in the early treatment of Parkinson's disease. , 1999, Canadian journal of physiology and pharmacology.

[19]  Clive N Svendsen,et al.  A new method for the rapid and long term growth of human neural precursor cells , 1998, Journal of Neuroscience Methods.

[20]  A. Levey,et al.  Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis , 1995, Annals of neurology.

[21]  J. Rothstein,et al.  Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. , 1992, The New England journal of medicine.

[22]  J. Coyle,et al.  Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis , 1990, Annals of neurology.

[23]  J. Lorden,et al.  Tolerance to the tremorogenic effects of harmaline: Evidence for altered olivo-cerebellar function , 1988, Neuropharmacology.

[24]  H. Iven,et al.  Pharmacokinetics in the rat of the hallucinogenic alkaloids harmine and harmaline , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[25]  T. Rauen,et al.  Regulation of glutamate transporters in health and disease. , 2001, Progress in brain research.

[26]  D. Nutt,et al.  beta-carboline binding to imidazoline receptors. , 2001, Drug and alcohol dependence.

[27]  R. Glennon,et al.  Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors. , 2000, Drug and alcohol dependence.

[28]  R. Ramsay,et al.  Inhibition of monoamine oxidase A by beta-carboline derivatives. , 1997, Archives of biochemistry and biophysics.

[29]  R. Ramsay,et al.  Inhibition of Monoamine Oxidase A by β-Carboline Derivatives , 1997 .